We are Sorry, This Page doesn't Exist

Biotech Analysis Central Pharma News: Roche Abandons Drug, Gilead"s Early Stage Bet, Vaxart"s Phase 2 Failure

Biotech Analysis Central Pharma News: Roche Abandons Drug, Gilead"s Early Stage Bet, Vaxart"s Phase 2 Failure.....»»

Category: topSource: seekingalphaJun 6th, 2018

Roche Announces Positive Data on Gazyva and MS Drug Ocrevus

Roche (RHHBY) announced positive long-term data on leukemia drug Gazyva and MS drug Ocrevus. Roche RHHBY announced encouraging data from the final analysis of the CLL11 study, evaluating Gazyva-based treatment in previously untreated.....»»

Category: smallbizSource: nytJun 15th, 2018

Biotech Analysis Central Pharma News: Celgene"s Protocol Change, Roche"s BLA For Herceptin, Amgen"s Resubmission For Osteoporosis

Biotech Analysis Central Pharma News: Celgene"s Protocol Change, Roche"s BLA For Herceptin, Amgen"s Resubmission For Osteoporosis.....»»

Category: topSource: seekingalphaJul 16th, 2018

Biotech Analysis Central Pharma News: Roche Raises Guidance, Biogen"s Alzheimer Promise, GlaxoSmithKline"s Panel Vote

Biotech Analysis Central Pharma News: Roche Raises Guidance, Biogen"s Alzheimer Promise, GlaxoSmithKline"s Panel Vote.....»»

Category: topSource: seekingalphaJul 27th, 2018

Biotech Analysis Central Pharma News: Roche"s EMA Advance, Pfizer"s New Strategy, Arrowhead"s First Amgen Milestone Payment

Biotech Analysis Central Pharma News: Roche"s EMA Advance, Pfizer"s New Strategy, Arrowhead"s First Amgen Milestone Payment.....»»

Category: topSource: seekingalphaAug 6th, 2018

Biotech Analysis Central Pharma News: Novartis" Positive News, Roche Unloads Drug, Zai Lab Suffers Failure

Biotech Analysis Central Pharma News: Novartis" Positive News, Roche Unloads Drug, Zai Lab Suffers Failure.....»»

Category: topSource: seekingalphaAug 28th, 2018

Roche announces launch of 3 new NGS AVENIO Tumor Tissue Analysis Kits

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 15th, 2018

Biotech Analysis Central Pharma News: Roche"s Deal, AcelRX Panel Vote, Crispr And Vertex Hold Removal

Biotech Analysis Central Pharma News: Roche"s Deal, AcelRX Panel Vote, Crispr And Vertex Hold Removal.....»»

Category: topSource: seekingalphaOct 17th, 2018

Downtown Crossing was once the busiest T station. Now there"s a new No. 1.

Downtown Crossing’s traffic was down 56% last year compared to five years earlier, according to a Boston Business Journal analysis of T data. For the past couple of years, the honor of the busiest station went to another Red Line stop a half-mile away......»»

Category: topSource: bizjournalsMay 3rd, 2024